Lisbon, 23 September 2024 – C-mo Medical Solutions, a leading innovator in cough monitoring technology, is pleased to announce the appointment of Chris Bergstrom as Chairman of the Board. Mr. Bergstrom brings decades of healthcare leadership, aiming to propel the company through its next phase of growth and innovation.

Mr. Bergstrom is a distinguished leader with over 20 years of experience in healthcare, spanning strategic and operational leadership roles in both MedTech and Digital Health. He has held leadership positions at major companies like P&G, Roche and Becton Dickinson, as well as at high-growth startups such as WellDoc and AmalgamRx. Chris has also furthered Boston Consulting Group’s (BCG) thought leadership across the globe as their first Digital Health Partner. His expertise in leveraging technology to improve patient outcomes aligns perfectly with C-mo Medical Solutions’ mission to revolutionize healthcare through AI-powered cough monitoring technologies.

“We are thrilled to welcome Chris Bergstrom as our new Board Chairman,” said Diogo Tecelão, CEO of C-mo Medical Solutions. “His extensive background in healthcare innovation and his strategic vision will be invaluable as we continue to advance our product offerings and expand our market presence. We look forward to working closely with Chris to propel C-mo Medical Solutions to new heights.”

As Chairman, Mr. Bergstrom will work closely with the executive team to provide strategic direction, enhance corporate governance, and drive the company’s long-term goals. His appointment comes at a pivotal time for C-mo Medical Solutions, as the company prepares to launch its groundbreaking cough monitor, designed to set new standards in the industry.

“I am honored to join C-mo Medical Solutions as Chairman of the Board,” said Chris Bergstrom. “The company’s potential to make a significant impact across biopharma’s therapeutic needs, provider care, and patient outcomes is inspiring. I look forward to collaborating with the talented team at C-mo Medical Solutions to drive forward our shared vision of revolutionizing the clinical management of cough-related diseases.”

With Chris Bergstrom leading the Board of Directors, C-mo Medical Solutions is well-positioned to continue its trajectory of success and make a meaningful difference in the lives of patients with chronic cough worldwide.

For more information, please contact:
[email protected]

About C-mo Medical Solutions:

C-mo Medical Solutions is a pioneering medical technology company focused on developing innovative solutions that improve patient care. The company’s mission is to unravel the clinical potential of cough assessment and solve the major unmet medical needs associated with the management of chronic cough.

The company’s proprietary cough monitoring device offers the most comprehensive assessment of cough traits, enabling an unparalleled characterization of the patient’s health status. It allows for an unobtrusive, long-term monitoring of patients with exceptional reliability, and is the first solution to ensure patient privacy by not recording any conversations. These features make C-mo the ideal solution for use in clinical trials, and to support healthcare professionals in diagnosing, treating, and managing chronic cough across diseases like idiopathic pulmonary fibrosis, cystic fibrosis, and COPD.

Find out more at www.c-mo.solutions.